ecrin-mdr-crcClinical2013metastatic colorectal cancerMetastatic Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2629292Japan1ECRIN MDRRecruitingfalseTS-1+ Oxaliplatin+ Bevacizumab therapy in consideration of OPTIMOX design for metastatic colorectal cancerInterventions: TS-1+ Oxaliplatin+ Bevacizumab/TS-1+ Bevacizumab Primary outcome(s): DDC ; Duration of disease control Study Design: Single arm Non-randomized2013-01-152629292JPRN-UMIN000013945